Breaks Categories: News

TuesdayMay 13, 2025 9:20 am

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Secures Orphan Drug Designation Transfer for TPI 287 in Brain Cancer Indications

CNS Pharmaceuticals (NASDAQ: CNSP) announced the successful transfer of Orphan Drug Designation from Cortice Biosciences for its lead asset TPI 287, covering gliomas, pediatric neuroblastoma, and progressive supranuclear palsy. TPI 287, a microtubule-stabilizing abeotaxane, has shown potential to cross the blood-brain barrier and demonstrated encouraging results in a Phase 1 glioblastoma trial, including 3 complete and 9 partial responses among 23 evaluable patients. The company plans to initiate a Phase 2 study by year-end 2025 and highlighted the potential benefits of Orphan status, including seven years of market exclusivity upon approval. To view the full press release, visit https://nnw.fm/IqmDh About…

Continue Reading

TuesdayMay 13, 2025 9:00 am

NetworkNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Subsidiary HOPE Therapeutics to Acquire Kadima Neuropsychiatry Institute

NRx Pharmaceuticals (NASDAQ: NRXP) announced that its wholly owned subsidiary, HOPE Therapeutics(TM), has signed a definitive agreement to acquire the Kadima Neuropsychiatry Institute. Kadima, a leading California clinic for interventional psychiatry, offers treatments such as ketamine, Spravato, transcranial magnetic stimulation (TMS), and medication management for CNS disorders including suicidal depression and PTSD. The clinic is profitable and expected to serve as the clinical model for future HOPE clinics. Dr. David Feifel, Kadima’s founder and a nationally recognized leader in interventional psychiatry, will join HOPE as its first Chief Medical Innovation Officer following the closing of the acquisition, which remains subject…

Continue Reading

MondayMay 12, 2025 1:57 pm

NetworkNewsBreaks – Aegis Capital Corp. Serves as Sole Book-Running Manager for Super League Enterprise (NASDAQ: SLE) $869,999 Public Offering

Aegis Capital is pleased to announce its role as the sole book-running manager in the recently completed underwritten public offering for Super League Enterprise, Inc. (NASDAQ: SLE). The offering comprised 5,117,647 shares of common stock at a public offering price of $0.17 per share, resulting in gross proceeds of approximately $869,999 before underwriting fees and expenses. The company also granted Aegis a 45-day overallotment option to purchase up to an additional 767,647 shares, which could increase total gross proceeds to $1 million if fully exercised.  Super League intends to use the net proceeds from the offering, combined with existing cash,…

Continue Reading

MondayMay 12, 2025 1:37 pm

NetworkNewsBreaks – CMB to Spotlight Future of Cannabis at NYC Expo 

Cannabis Means Business (“CMB”), the industry’s premier business-to-business conference and expo, today shared new details on its schedule of panels and presentations, as well as programming, exhibitions and networking opportunities. The expo will feature a lineup of engaging speakers, including CNBC Fast Money trader Tim Seymour, Philip Wolf, a pioneer of the cannabis hospitality sector. and Dr. Chanda Macias, CEO of Women Grow.  “New York's rapidly growing cannabis market, combined with its unmatched consumer base and global reach, creates a unique opportunity for businesses to thrive—and makes it the perfect backdrop for our event,” said CMB CEO and Founder Christine…

Continue Reading

MondayMay 12, 2025 1:00 pm

NetworkNewsBreaks – IBN Tapped as Media Partner for DealFlow Discovery Day on Nuclear Energy

IBN (InvestorBrandNetwork), a multifaceted communications organization committed to connecting companies with the investment community through its dynamic portfolio of 60+ brands, today announced its engagement as the official media partner for DealFlow Events’ inaugural DealFlow Discovery Day on Nuclear Energy. The event is slated to take place on May 22, 2025, at the conveniently located Jay Suites in New York City. "DealFlow produces industry-flagship events for investors and financial market participants. The upcoming conference will offer highly specialized educational and networking opportunities in the rapidly emerging nuclear energy space,” said IBN’s Director of Global Operations Randy Clark. “Our team is…

Continue Reading

MondayMay 12, 2025 11:33 am

NetworkNewsBreaks – Brera Holdings PLC (NASDAQ: BREA) to Stream Juve Stabia Finale Live in U.S., Canada and UK 

Brera Holdings (NASDAQ: BREA) announced that its Italian Serie B club S.S. Juve Stabia, known as “The Second Team of Naples,” will have its regular season finale streamed live and free on Tuesday, May 13, at 2:30 p.m. ET via Destination Calcio(TM) TV for viewers in the U.S., Canada and UK. The match, featuring Juve Stabia at home against Sampdoria, will include full English commentary and be available on the Destination Calcio(TM) app and website. The broadcast supports Brera’s multi-club ownership strategy by boosting the team’s international exposure and building its fan base in key markets.  To view the full…

Continue Reading

MondayMay 12, 2025 11:21 am

NetworkNewsBreaks – Nightfood Holdings Inc. (OTCQB: NGTF) Signs LOI to Acquire Hilton Garden Inn Near Disney’s Cotino Project 

Nightfood Holdings (OTCQB: NGTF) announced the signing of a Letter of Intent to acquire the 120-room Hilton Garden Inn in Rancho Mirage, California for $36.93 million, marking one of the company’s largest deals to date. The hotel, adjacent to Disney’s Cotino(TM) residential resort community, will serve as a flagship site for Nightfood’s AI-powered Robotics-as-a-Service (“RaaS”) platform, which aims to reduce labor costs and enhance operational efficiency. The acquisition includes plans for a five-room expansion, a $3 million earn-out, and $26.43 million in Series C Preferred Stock, contingent on financial audits, mortgage conditions, and uplisting to a national exchange.  To view…

Continue Reading

MondayMay 12, 2025 11:06 am

NetworkNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Report Q1 2025 Results on May 15 

NRx Pharmaceuticals (NASDAQ: NRXP) announced it will release its first quarter 2025 financial results after market close on Thursday, May 15, 2025. The company will host a conference call at 4:30 p.m. ET the same day to discuss the results and provide a corporate update.  To view the full press release, visit https://nnw.fm/UGA07  About NRx Pharmaceuticals, Inc.  NRx Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for the treatment of central nervous system disorders, specifically suicidal bipolar depression, chronic pain, and PTSD. The Company is developing NRX-101, an FDA-designated investigational Breakthrough Therapy for suicidal treatment-resistant…

Continue Reading

MondayMay 12, 2025 10:50 am

NetworkNewsBreaks – Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) Plans $1 Million Private Placement with Major Shareholder HCI

Platinum Group Metals (NYSE American: PLG) (TSX: PTM) announced plans to raise approximately $1.01 million through a private placement of 800,000 common shares at $1.26 per share to major shareholder Hosken Consolidated Investments Limited ("HCI"), pending regulatory approval. The proceeds will support the company's share of pre-construction activities at the Waterberg Project in South Africa and general corporate needs. The placement price reflects a 3.1% premium to the five-day VWAP on NYSE American as of May 9. Upon completion, HCI will return to a 26% ownership stake. The shares will be subject to a four-month-plus-one-day resale restriction and were offered…

Continue Reading

MondayMay 12, 2025 9:10 am

NetworkNewsBreaks – NUBURU, Inc. (NYSE American: BURU) Receives Noncompliance Notice from NYSE American Over Equity Threshold

NUBURU (NYSE American: BURU) has received a Notice of Noncompliance from NYSE Regulation for failing to meet the $2 million stockholders’ equity requirement under Section 1003(a)(i) of the NYSE American Company Guide, following continued operating losses and a going concern warning in its latest 10-K. The notice does not immediately impact BURU's trading status, though its ticker now carries a ".BC" designation. The company has until May 29 to submit a plan to regain compliance and until Oct. 29, 2026 to meet the listing standards. Management cited recent strategic initiatives as potential paths to compliance, though their success is not…

Continue Reading